Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0S2QI
|
||||
Former ID |
DNC000992
|
||||
Drug Name |
Naproxene
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Pain; Endometriosis [ICD9: 338, 617.0,780; ICD10:N80, R52, G89] | Investigative | [536772] | ||
Therapeutic Class |
Analgesics
|
||||
Structure |
Download2D MOL |
||||
Formula |
C14H14O3
|
||||
Canonical SMILES |
CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O
|
||||
InChI |
1S/C14H14O3/c1-9(14(15)16)10-3-4-12-8-13(17-2)6-5-11(12)7-10/h3-9H,1-2H3,(H,15,16)/t9-/m0/s1
|
||||
InChIKey |
CMWTZPSULFXXJA-VIFPVBQESA-N
|
||||
CAS Number |
CAS 22204-53-1
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
4682, 597410, 3248704, 7847186, 7980083, 8149438, 10252902, 10321400, 11112669, 11335417, 11360656, 11363871, 11366433, 11368995, 11371667, 11373736, 11377157, 11461628, 11466819, 11467939, 11484702, 11486597, 11488859, 11490330, 11491884, 11494791, 15172373, 15172374, 22391409, 24857178, 24870224, 24883816, 24897861, 25649496, 26527900, 26611833, 26679674, 26755231, 46232210, 46487915, 46505508, 47291026, 47588882, 47810639, 48334369, 48334370, 48426145, 49833549, 50025704, 50103854
|
||||
SuperDrug ATC ID |
G02CC02
|
||||
SuperDrug CAS ID |
cas=022204531
|
||||
Target and Pathway | |||||
Target(s) | Prostaglandin G/H synthase 2 | Target Info | Inhibitor | [536772] | |
KEGG Pathway | Arachidonic acid metabolism | ||||
Metabolic pathways | |||||
NF-kappa B signaling pathway | |||||
VEGF signaling pathway | |||||
TNF signaling pathway | |||||
Retrograde endocannabinoid signaling | |||||
Serotonergic synapse | |||||
Ovarian steroidogenesis | |||||
Oxytocin signaling pathway | |||||
Regulation of lipolysis in adipocytes | |||||
Leishmaniasis | |||||
Pathways in cancer | |||||
Chemical carcinogenesis | |||||
MicroRNAs in cancer | |||||
Small cell lung cancer | |||||
PathWhiz Pathway | Arachidonic Acid Metabolism | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.